anonymous
Guest
anonymous
Guest
Track record so far…
- No commercial success with LEQVIO, and all in strategy on population health failing in most countries
- Optha disaster, no improvements in market share or sales — complete abandonment of the franchise now
- Respiratory failure, while Fevi not totally her fault, lack of any vision for the future is clear
- Deprioritization of gene therapy franchise globally, huge mistake
- Placing leaders into position who don’t challenge and are just “yes” people
- Most uninspiring leader ever — no ability to have genuine conversations and is colder then Pluto
- Horrible strategic mindset and can only see 6 months ahead (clear with failures)
- Horrible strategy globally on Cosentyx
- Time to ruin Oncology more than S.S. has done
- Glint survey possible the worst across all companies that Glint measures
- Most times it’s like speaking to a robot who’s been programmed with key messages (horrible)